Jacobs Levy Equity Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-12,256
| Closed | -$315K | – | 1119 |
|
|
2020
Q2 | $315K | Hold |
12,256
| – | – | ﹤0.01% | 879 |
|
|
2020
Q1 | $188K | Sell |
12,256
-206,159
| -94% | -$3.16M | ﹤0.01% | 896 |
|
|
2019
Q4 | $7.49M | Buy |
218,415
+20,488
| +10% | +$703K | 0.07% | 300 |
|
|
2019
Q3 | $1.48M | Buy |
197,927
+81,243
| +70% | +$607K | 0.02% | 563 |
|
|
2019
Q2 | $1.52M | Buy |
116,684
+7,100
| +6% | +$92.2K | 0.02% | 568 |
|
|
2019
Q1 | $1.34M | Buy |
109,584
+37,570
| +52% | +$458K | 0.02% | 600 |
|
|
2018
Q4 | $820K | Buy |
72,014
+61,389
| +578% | +$699K | 0.01% | 641 |
|
|
2018
Q3 | $231K | Sell |
10,625
-2,295
| -18% | -$49.9K | ﹤0.01% | 910 |
|
|
2018
Q2 | $228K | Buy |
+12,920
| New | +$228K | ﹤0.01% | 933 |
|
|
2018
Q1 | – | Sell |
-16,770
| Closed | -$243K | – | 1073 |
|
|
2017
Q4 | $243K | Buy |
16,770
+5,100
| +44% | +$73.9K | ﹤0.01% | 870 |
|
|
2017
Q3 | $184K | Buy |
+11,670
| New | +$184K | ﹤0.01% | 877 |
|
|
2016
Q2 | – | Sell |
-53,224
| Closed | -$1.48M | – | 1242 |
|
|
2016
Q1 | $1.48M | Buy |
+53,224
| New | +$1.48M | 0.03% | 482 |
|